their national priorities with acceptable differences in some of the still controversial points. However, there were some topics that should have some coincidences, such as the optimal peak expiratory flow (PEF) used when deciding a patient's discharge from the emergency room (ER). It was amazing to realize that the percent predicted PEF value recommended to decide discharge from the ER varied from 50 to 75% (Argentinean 60%, British 75%, Canadian 50%, American 70%). There was no mention of acute asthma management in the Australian report.' For a patient with a predicted PEF of 600 L/min, the Canadian physicians would discharge at a PEF of 300 L/min and the British doctors would not discharge until 450 L/min. In this way, the hospitals in Great Britain would be crowded by asthmatics that could be treated at the ambulatory setting. On the other hand, asthmatics from Canada were at a higher risk of relapse. Which PEF is the best PEF for deciding discharge? There is some evidence, although weak in nature, that supports the 60% of predicted PEF as the best value.
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In a review of management of acute life-threatening asthma,6 an FEV, of at least 60% of predicted has been suggested as the cutoff point between discharge and admission. In another study,7 the patients without relapse had been discharged with However, we were also somewhat surprised that the authors did not reference either our article since it had been published one month prior to Chest receiving the accepted revision by Anderson in November 1993 or our abstract3 that had been published in 1992. We reported in Chest that our results from 145 fine-needle aspirations (FNA) suggested the development of a pneumothorax is not related to the presence of an obstructive or restrictive defect as measured by spirometry. Our conclusions now appear to be further supported by the results obtained by Anderson et al. However, it remains still to be explained why the pneumothorax rate in our series was 20.2% (18/89) and for the Anderson et al group was 35.4% (33/93) even though the patients and the methodology were similar. The findings of both studies are in our opinion consistent with the hypothesis (proposed in our earlier manuscript) that post-FNA pneumothorax is related to a combination of technical and possibly operator-related factors, eg, the size and number of bullae along the tract of the aspiration needle or the number of actual needle "passes." Further supporting this hypothesis is the pneumothorax rate of 14% (21/145) for our total FNA group, ie, those with and without spirometry. This rate is the lowest that we could find in our search of the literature, which also now includes the recent Anderson et al article.
We remain convinced that in this clinical setting the development of a pneumothorax, post-fine-needle aspiration of a lung lesion, is related to a combination of technical and operatorrelated factors that are yet to be definitively established.
